MELAS syndrome – Life with Disease

Go back

MELAS syndrome is a rare inherited condition that affects the body’s ability to produce energy, primarily impacting the nervous system and muscles. This genetic disorder typically appears during childhood and causes a range of challenging symptoms, including stroke-like episodes, seizures, and progressive neurological decline. Understanding what to expect and how to cope with this condition can help patients and families navigate the difficult journey ahead.

Prognosis: Understanding What Lies Ahead

When families first hear the diagnosis of MELAS syndrome, one of the most difficult questions to face is what the future holds. This is understandably a sensitive topic that deserves honest yet compassionate discussion. MELAS syndrome is a progressive condition, which means symptoms typically worsen over time rather than staying stable or improving[1].

The outlook for individuals with MELAS syndrome is unfortunately serious. Research indicates that most individuals survive approximately 17 years following the onset of seizures or other nervous system problems[3]. However, it’s important to understand that MELAS affects each person differently, and the rate of progression can vary considerably from one individual to another[8].

The syndrome is characterized by progressive deterioration of the nervous system, which leads to neurological impairment and often dementia (a decline in memory and thinking abilities) in adolescence or early adulthood[2]. This progressive nature means that abilities and functions that were once present may gradually decline as the disease advances.

Many people with MELAS experience repeated stroke-like episodes, and each of these events can progressively damage the brain. Over time, this repeated damage can lead to vision loss, problems with movement, and loss of intellectual function[4]. The accumulation of damage from multiple episodes makes the overall prognosis more challenging.

Despite these difficult realities, it’s crucial to know that supportive treatments are available that can make a meaningful difference in quality of life[3]. While medical research has not yet established a means of stopping or reversing MELAS, ongoing studies continue to search for better ways to manage symptoms and potentially slow disease progression.

How the Disease Develops Without Treatment

Understanding the natural progression of MELAS syndrome helps families know what changes to anticipate. Most children with MELAS experience a period of normal early development before symptoms begin[2]. This means that for the first months or even years of life, the child may appear completely healthy and reach typical developmental milestones.

The onset of symptoms typically occurs in childhood, most commonly between the ages of 2 and 15 years[2]. However, symptoms can appear as early as before age 2 or as late as after age 40[3]. Nearly 75 percent of cases are diagnosed before the age of 20[5].

When symptoms do begin, they often start suddenly. Children may experience recurrent attacks of migraine-like headaches, loss of appetite, vomiting, and seizures[6]. These initial symptoms can sometimes be confusing because they may come and go, occasionally even disappearing for a period before returning and progressing more aggressively.

As the disease advances, the hallmark stroke-like episodes become more prominent. These episodes involve sudden neurological symptoms such as temporary muscle weakness on one side of the body, altered consciousness, vision problems, seizures, and severe headaches[4]. Unlike actual strokes caused by blocked blood vessels, these episodes in MELAS are thought to result from the brain’s inability to produce enough energy.

Over time, affected individuals experience increasing difficulties across multiple body systems. The nervous system deterioration becomes more evident, with problems in thinking, behavior changes, and difficulty with coordination becoming more pronounced. The muscle weakness that characterizes the condition tends to worsen, making physical activities increasingly difficult.

Without intervention to manage symptoms, individuals may experience more frequent and severe episodes. The accumulation of brain damage from repeated stroke-like episodes leads to progressive cognitive decline. Movement difficulties become more limiting, and the ability to perform daily activities independently decreases as the disease advances.

Possible Complications

MELAS syndrome can lead to a wide range of complications affecting multiple organ systems. Because mitochondria (the energy-producing structures within cells) are present in nearly all cells of the body, problems can develop in any tissue or organ[1].

One of the most significant complications is intellectual disability, which can progress to dementia[1]. This means that affected individuals may experience declining mental abilities, including problems with memory, reasoning, and decision-making. These cognitive changes can be particularly distressing for families as they watch their loved one’s personality and abilities change.

Diabetes is a common complication of MELAS syndrome. In fact, almost all people with MELAS develop diabetes and hearing loss before the onset of brain-related symptoms[1]. The diabetes that occurs with MELAS requires careful management to prevent additional health problems.

Hearing problems are another frequent complication[1]. The hearing loss can range from mild to severe and may worsen over time. This sensory impairment adds another layer of difficulty to communication and daily functioning.

Vision loss is a serious complication that can occur through several mechanisms. Some individuals experience cortical blindness (vision loss caused by damage to the part of the brain that processes visual information) as a result of stroke-like episodes[3]. Others may have partial loss of vision or double vision.

Muscle-related complications include spasms and lack of control[1]. These muscle problems can affect mobility and make everyday tasks like walking, eating, or dressing extremely challenging. Gait and balance issues further increase the risk of falls and injuries.

Heart problems can develop in some individuals with MELAS. The heart is a muscle that requires enormous amounts of energy to function properly, making it particularly vulnerable to mitochondrial dysfunction. Similarly, kidney problems and liver problems can occur as complications of the disease[1].

⚠️ Important
Stroke-like episodes are medical emergencies that require immediate attention. If someone with MELAS experiences sudden weakness on one side of the body, vision changes, confusion, or severe headache, seek medical care right away. Early treatment during these episodes may help reduce brain damage.

Impact on Daily Life

Living with MELAS syndrome affects virtually every aspect of daily life, creating challenges that extend far beyond the physical symptoms. The progressive nature of the disease means that individuals and families must continually adapt to changing abilities and needs.

Physical activities become increasingly difficult as muscle weakness and fatigue worsen. Simple tasks that most people take for granted—such as climbing stairs, carrying groceries, or even getting dressed—can become exhausting or impossible without assistance. The unpredictable nature of the disease adds another layer of difficulty, as individuals may feel relatively well one day and severely fatigued the next.

The stroke-like episodes that characterize MELAS create ongoing anxiety and uncertainty. Families never know when an episode might occur, making it difficult to plan activities or maintain normal routines. After an episode, there may be temporary or permanent losses in function that require adjustment and rehabilitation.

Cognitive changes significantly impact daily functioning and independence. As intellectual abilities decline, individuals may struggle with tasks that require problem-solving, memory, or judgment. This can affect everything from managing medications to handling finances to maintaining personal safety.

Emotional and mental health challenges are common for people living with MELAS. Anxiety and depression frequently accompany the condition[3]. The awareness of progressive decline, combined with the physical limitations and loss of independence, can take a tremendous emotional toll. Young people with MELAS may grieve the loss of their imagined future and struggle with feelings of isolation from their peers.

Social life often suffers as the disease progresses. Fatigue, seizures, hearing loss, and cognitive changes can make social interactions exhausting or embarrassing. Children and adolescents with MELAS may find it difficult to participate in school activities or maintain friendships. Adults may need to reduce work hours or stop working entirely, losing not only income but also the social connections and sense of purpose that employment provides.

Education and work present particular challenges. Learning disabilities are common in individuals with MELAS[3], and the progressive cognitive decline makes maintaining academic performance increasingly difficult. Many individuals require special education services or accommodations. For adults in the workforce, the unpredictable symptoms and declining abilities often force difficult decisions about career goals and employment.

Family roles and relationships change as the disease progresses. A child with MELAS requires increasing levels of care and supervision, placing enormous demands on parents and siblings. An adult with MELAS may shift from being an independent contributor to the household to requiring significant assistance, fundamentally altering family dynamics.

Managing the practical aspects of life with MELAS is a full-time challenge. There are frequent medical appointments with multiple specialists, medications to coordinate, dietary considerations, and equipment needs. The financial burden of the disease can be substantial, including medical costs, medications, adaptive equipment, and potentially lost income if caregivers must reduce work hours.

Despite these challenges, many families develop effective coping strategies. Breaking tasks into smaller, manageable steps can help conserve energy. Establishing predictable routines provides structure and reduces cognitive demands. Using assistive devices and making home modifications can maintain independence longer. Connecting with others who understand the disease through support groups provides emotional support and practical advice.

Support for Family Members

For families facing a MELAS diagnosis, understanding clinical trials and research opportunities is an important aspect of care. Clinical trials represent hope for better treatments in the future while potentially providing access to new therapies for current patients.

Clinical trials for MELAS are actively recruiting participants[3]. These research studies test new medications, therapies, or approaches to managing the condition. Participation in clinical trials serves two purposes: it may provide the individual with access to cutting-edge treatments not yet available to the general public, and it contributes valuable data that helps advance understanding of the disease for future patients.

Families should know that joining a patient registry is another way to contribute to research efforts. Patient registries like mitoSHARE are actively recruiting MELAS families[3]. These registries collect information about individuals with the condition, helping researchers understand disease patterns, identify potential research participants, and develop better treatments. Registration is typically straightforward and doesn’t require the same level of commitment as participating in a clinical trial.

When considering clinical trial participation, families should understand what’s involved. Researchers will explain the study’s purpose, what treatments or procedures are being tested, potential benefits and risks, and what participation will require in terms of visits, tests, and time commitment. It’s completely acceptable to ask questions and take time to make an informed decision.

Finding relevant clinical trials can feel overwhelming, but resources exist to help. Clinical trial finder tools are available specifically for MELAS[3]. These tools allow families to search for studies based on location, age, disease stage, and other factors to identify trials that might be appropriate.

Family members can actively support their loved one by researching available trials and helping evaluate whether participation makes sense for their situation. This might involve reviewing study information together, preparing questions for the research team, attending informational meetings, or helping coordinate the logistics of participation.

Support organizations play a crucial role in connecting families with clinical trial opportunities. Organizations that serve mitochondrial disease patients maintain updated information about ongoing research and can help families navigate the process of finding and enrolling in appropriate studies. Many organizations also have support teams available by email or phone to answer questions and provide guidance[3].

Genetic counseling is often recommended for families affected by MELAS[3]. Because MELAS is inherited through mitochondrial DNA passed from mothers to children, genetic counselors can help families understand inheritance patterns, assess risks for other family members, and make informed decisions about family planning.

Beyond research participation, families need practical and emotional support. Connecting with other families facing MELAS can be invaluable. Many find comfort in knowing they’re not alone and appreciate learning from others’ experiences. Support organizations often facilitate connections between families through support meetings, online forums, or ambassador programs that pair newly diagnosed families with experienced ones[3].

⚠️ Important
Only women can pass MELAS syndrome to their children, even though the condition affects both males and females equally. If you have MELAS in your family, particularly if your mother has the condition, genetic counseling can help you understand the implications for you and future generations.

💊 Registered drugs used for this disease

List of officially registered medicines that are used in the treatment of this condition, based only on the provided sources:

  • Coenzyme Q10 – A supplement that may increase mitochondrial energy output and potentially slow disease progression in some individuals
  • L-carnitine – A supplement that may help increase mitochondrial energy production and provide general benefit in some individuals
  • L-arginine – Used during acute stroke-like episodes to help reduce brain damage by improving blood vessel function and increasing nitric oxide availability
  • L-citrulline – A supplement that acts as a nitric oxide precursor and may help prevent stroke-like episodes
  • Antiseizure medications – Used to manage seizures associated with MELAS (though valproate should be avoided)
  • Insulin – Used to manage diabetes that commonly develops in people with MELAS

Ongoing Clinical Trials on MELAS syndrome

  • Long-term safety study of zagociguat tablets in patients with MELAS syndrome (Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes) who completed previous trial

    Not yet recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Germany Italy
  • Study on the Safety and Effectiveness of Zagociguat for Treating MELAS in Patients

    Not recruiting

    Investigated diseases:
    Investigated drugs:
    Germany Italy
  • Study on the Effects of TTI-0102 for Patients with MELAS Syndrome

    Not recruiting

    Investigated diseases:
    France The Netherlands

References

https://my.clevelandclinic.org/health/diseases/25149-melas-syndrome

https://www.ncbi.nlm.nih.gov/books/NBK532959/

https://umdf.org/melas/

https://medlineplus.gov/genetics/condition/mitochondrial-encephalomyopathy-lactic-acidosis-and-stroke-like-episodes/

https://www.cedars-sinai.org/health-library/diseases-and-conditions/m/melas.html

https://en.wikipedia.org/wiki/MELAS_syndrome

https://emedicine.medscape.com/article/946864-overview

https://www.rareportal.org.au/rare-disease/melas/

FAQ

Can MELAS syndrome be cured?

Unfortunately, there is currently no cure for MELAS syndrome. Medical research has not yet established a means of stopping or reversing the disease. However, supportive treatments are available that can help manage symptoms and improve quality of life for affected individuals and their families.

How is MELAS syndrome inherited?

MELAS syndrome is inherited through mitochondrial DNA, which is passed exclusively from mother to child. This means only women can pass the condition to their children, though both males and females can be affected. Fathers with MELAS cannot transmit the condition to their offspring because sperm do not contribute mitochondria during fertilization.

At what age do symptoms of MELAS typically start?

Most people with MELAS show signs by or before age 20, with symptoms typically appearing between ages 2 and 15. However, the disease can begin as early as before age 2 or as late as after age 40. Children usually experience a period of normal early development before symptoms begin.

What are stroke-like episodes in MELAS?

Stroke-like episodes are sudden neurological events that resemble strokes but have a different cause. They involve symptoms such as temporary muscle weakness on one side of the body, altered consciousness, vision abnormalities, seizures, and severe headaches. Unlike regular strokes caused by blocked blood vessels, these episodes result from the brain’s inability to produce enough energy due to mitochondrial dysfunction.

Can clinical trials help people with MELAS?

Clinical trials may provide access to new treatments not yet available to the general public while contributing to research that helps future patients. Clinical trials for MELAS are actively recruiting participants, and joining a patient registry like mitoSHARE can help connect families with research opportunities. Participation in research is voluntary and families should carefully consider the potential benefits and requirements before enrolling.

🎯 Key takeaways

  • MELAS syndrome affects approximately 1 in 4,000 people, making it one of the more common mitochondrial diseases, though still considered rare.
  • The condition is progressive and unfortunately often fatal, with most individuals surviving approximately 17 years following the onset of seizures or nervous system problems.
  • Almost all people with MELAS develop diabetes and hearing loss before neurological symptoms appear, serving as early warning signs.
  • The syndrome is inherited exclusively through the maternal line—only mothers can pass MELAS to their children, never fathers.
  • Stroke-like episodes in MELAS are caused by energy failure in the brain, not blocked blood vessels, requiring different treatment approaches than traditional strokes.
  • While there’s no cure, several treatments including L-arginine therapy during acute episodes and supplements like Coenzyme Q10 may help manage symptoms.
  • The anticonvulsant medication valproate should be specifically avoided in MELAS patients as it can worsen the condition.
  • Active clinical trials and patient registries offer hope for better treatments while providing families with opportunities to contribute to research that may help future generations.